Neoadjuvant Therapy in the Treatment of Breast Cancer.
Neoadjuvant Therapy in the Treatment of Breast Cancer.
Surg Oncol Clin N Am. 2014 Jul;23(3):505-523
Authors: Teshome M, Hunt KK
Abstract
Neoadjuvant systemic therapy in breast cancer treatment was initially utilized for inoperable disease. However, several randomized prospective studies have demonstrated comparable survival with adjuvant chemotherapy in early-stage, operable breast cancer while also decreasing tumor size facilitating breast conservation without significant increases in local recurrence. Response to therapy can predict outcome, with improved survival associated with pathologic complete response (pCR). Triple negative and HER2-positive subtypes show increased pCR rates. A multidisciplinary approach is necessary with neoadjuvant treatment. This can improve rates of breast conservation, provide insights into tumor biology and predict patient outcomes.
PMID: 24882348 [PubMed - as supplied by publisher]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Teshome M, Hunt KK Tags: Surg Oncol Clin N Am Source Type: research
More News: Biology | Breast Cancer | Breast Conservation Surgery | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study